Old version — revision 1
This is a fixed snapshot of Procreative beneficence, saved by Import as part of the initial corpus import. It is not edited and it is not updated; the article may have changed since.
Edit summary: Initial import of content/procreative-beneficence.md — the filesystem corpus, unchanged. Not an edit.
Julian Savulescu's principle that prospective parents have moral reason to select, among the children they could have, the one expected to live the best life.
Procreative beneficence is the principle, stated by Julian Savulescu in 2001, that couples who select which of several possible children to bring into existence have significant moral reason to choose the one expected to have the best life, or at least as good a life as the alternatives, on the basis of the relevant information available — including information about traits that are not diseases.1 It is one of the most cited claims in contemporary reproductive ethics and one of the most widely rejected. Its practical bite has grown as Embryo selection has moved from testing for single-gene conditions to scoring embryos on statistical predictors of common traits.
Three features are load-bearing and routinely misread.
It is a principle about selection, not modification. It says nothing about Human germline editing and applies wherever a choice is made among possible children — which embryo to transfer, which gamete donor to use, and in a weaker sense when to conceive.
It generates a reason, not an enforceable duty. Savulescu is explicit that the obligation is prima facie and that it does not license coercion, state direction, or the withdrawal of reproductive liberty. On his account a couple who decline to test, or who transfer an embryo with a lower expected wellbeing, act against a reason they have; they do not thereby become subject to interference.
It ranges over wellbeing, not health. The principle is deliberately not restricted to disease, because Savulescu regards the therapy line criticised in Bioethics of enhancement as arbitrary. If a trait makes a life go better, it counts, which places the principle squarely inside the argument about Human enhancement rather than beside it. In later work with Guy Kahane the formulation was revised to the child with the best chance of the best life, acknowledging that prediction is probabilistic.2
The relation to eugenicsHistorical eugenics was state-directed, coercive, and aimed at population-level genetic quality. Procreative beneficence is individual, non-coercive, and aimed at the welfare of a particular child. Critics accept the distinction and argue that the aggregate of many uncoordinated private choices can produce the population-level effects the state was condemned for pursuing, without anyone having intended them.
The principle's philosophical foundation, and its central vulnerability, is the non-identity problem set out by Derek Parfit.3 Choosing embryo A over embryo B does not make anyone better or worse off, because the alternative for A's life is not a worse life but no life. Nobody is harmed by not being selected, and the child who results cannot complain of a choice without which they would not exist.
This blocks the obvious person-affecting justification for selection and forces the principle onto impersonal ground: the reason to select the better-off child is that it is better for the world to contain a better life, not better for anyone. Critics regard this as the weak point. Rebecca Bennett has argued that once the impersonal move is made, procreative beneficence loses its intuitive force — the claim that one has moral reason to produce a somewhat happier person, rather than a differently constituted equally real person, is not obviously true and is not established by the intuitions the principle recruits.4
The same structure creates a symmetrical difficulty for critics. The expressivist objection holds that selecting against a trait sends a demeaning message about people who have it. But if no particular person is harmed by non-selection, the objection must also be about meaning rather than harm, and both sides end up arguing about what choices express rather than about what they do. Disability rights and enhancement develops that objection on its own terms.
It presupposes a theory of the good life. To rank possible children one needs a metric. Savulescu appeals to general-purpose means — health, intelligence, self-discipline — on the ground that they help under most conceptions of a good life. Michael Parker's reply is that reasonable parents disagree profoundly about what makes a life go well, and that a principle requiring them to select on a metric they reject is not neutral but substantive.5
It over-generates. Taken literally, the principle applies to every reproductive decision, including timing, partner choice, and whether to reproduce at all. Few of its defenders accept the implications at that scope.
It licenses selection on socially advantageous rather than intrinsically good traits. If a trait improves a life only because society rewards it — height, or a majority ethnic appearance — then selecting for it adapts children to injustice rather than correcting it. Savulescu accepts this consequence in some cases, which several critics treat as a reductio. Robert Sparrow has pressed the point hardest, arguing that consistently applied the principle recommends selection profiles that its proponents would not defend in public.6 The same structure recurs in the popular framing of Designer babies, where the traits imagined as purchasable are almost all positional.
It sits awkwardly with the author's other commitments. Savulescu's case for Moral enhancement rests on the claim that human dispositions are dangerously ill-suited to modern conditions. If that is right, the traits a parent should select for are not the ones that make a child's own life go best, and the principle points in a different direction from its author's other work.
It assumes the prediction works. This is the objection that has strengthened most since 2001.
When Savulescu wrote, selection meant testing for single-gene conditions with near-deterministic effects. The principle's modern application is Polygenic embryo screening, which scores embryos on aggregates of thousands of common variants, and the technical difficulties there constrain what the principle can actually recommend.
Polygenic scores are validated mostly by comparing unrelated people, where they capture population structure and environmental confounding along with genetic effect. Selection among siblings is a within-family comparison, in which those confounds are removed and predictive power falls substantially. Modelling work has put the expected gain from choosing the top-scoring embryo out of ten at a few centimetres of height or a few points of measured cognitive ability, with wide uncertainty around each individual case, and considerably less for embryos whose ancestry is not represented in the training data.7 A commentary in a major medical journal set out the same limitations for clinicians.8 Professional genetics societies in Europe and North America have advised against clinical use of polygenic embryo scoring on these grounds.
The practical ceiling is not only statistical. A stimulation cycle yields a limited number of viable embryos — often fewer than five for older patients — and the gain from selection grows only very slowly as that number rises. In vitro gametogenesis, if it ever works in humans, would remove that constraint and is the development that would make procreative beneficence a decision of consequence rather than a philosophical exercise.
Small effects, large implicationsDefenders argue that a small expected benefit is still a benefit, and that the principle does not require large effects to hold. Opponents reply that a principle whose real-world application yields an uncertain fraction of a standard deviation, while restructuring how parents relate to their children, is a poor trade — and that the moral cost is incurred whether or not the prediction pays off.
Procreative beneficence has not been adopted by any professional body or embedded in any regulation. UK law instead directs clinics to consider the welfare of the child, a weaker and vaguer standard that does not rank possible children against one another. Where selection is regulated at all, it is regulated by listing permitted indications rather than by any general principle about wellbeing.
Its influence has been on the shape of the debate. It forced defenders of selection-for-disease to explain why the same reasoning stops at disease, and it forced opponents of enhancement, including the writers surveyed under Bioconservatism, to say what is wrong with wanting a child's life to go well. It also supplied the ethical vocabulary now used by companies marketing embryo scoring directly to consumers, generally without the qualifications Savulescu attached — a commercial setting in which the distribution of the service determines who can act on the principle at all. Whether a principle can be responsible for the uses made of it in a commercial setting it did not anticipate is a question its author has addressed and his critics do not consider settled.
paperSavulescu, J. "Procreative Beneficence: Why We Should Select the Best Children." Bioethics, 2001. ↩
paperSavulescu, J. and Kahane, G. "The Moral Obligation to Create Children with the Best Chance of the Best Life." Bioethics, 2009. ↩
bookParfit, D. Reasons and Persons. Oxford University Press, 1984. ↩
paperBennett, R. "The Fallacy of the Principle of Procreative Beneficence." Bioethics, 2009. ↩
paperParker, M. "The Best Possible Child." Journal of Medical Ethics, 2007. ↩
paperSparrow, R. "A Not-So-New Eugenics: Harris and Savulescu on Human Enhancement." Hastings Center Report, 2011. ↩
paperKaravani, E. et al. "Screening Human Embryos for Polygenic Traits Has Limited Utility." Cell, 2019.↩The modelled gains assume a choice among ten embryos, more than a typical stimulation cycle yields.
paperTurley, P. et al. "Problems with Using Polygenic Scores to Select Embryos." New England Journal of Medicine, 2021.↩A critique setting out the limitations of embryo polygenic scores rather than reporting a new study of them.